Page 39 - Heca News Today

AbbVie Inc and partner Johnson & Johnson intend to voluntarily withdraw the accelerated approvals of their Imbruvica drug in the U.S. for patients with certain types of blood cancer, the companies said on Thursday.

AstraZeneca on Wednesday said a combination of its cancer drugs Imfinzi and Lynparza met the main goal in a late-stage trial in patients with advanced ovarian cancer.

Major stock markets in the Gulf were subdued in early trade on Wednesday, as signs of a slowing U.S. labour market made investors nervous about the economic outlook.

Most stock markets in the Gulf ended lower on Wednesday in line with global shares as signs that the economic outlook is weakening spurred caution.

The Philippines will in June auction rights to build up to 11,600 megawatts of new power capacity from renewable sources in the next three years, the Department of Energy said, as it seeks to gradually reduce its reliance on coal.

No contamination was found in samples of eye drops made by India's Global Pharma Healthcare, a product linked to three deaths and blindness in some patients in the U.S., broadcaster NDTV reported on Tuesday citing India's health ministry sources.

London's FTSE 100 ended lower on Tuesday, a day after hitting a three-week high, bogged down by a stronger pound and weakness in the shares of oil majors.

Mexican President Andres Manuel Lopez Obrador said on Tuesday he had sent a letter to his Chinese counterpart Xi Jinping urging him to help control shipments of the synthetic opioid fentanyl sent across the Pacific.

J&J is exploring placing a subsidiary shouldering tens of thousands of talc lawsuits into bankruptcy proceedings for a second time, despite a court decision invalidating the legal maneuver.

Generic drugmaker Stada has asked the German government to seek assurances from Ukraine that the company can continue operations there even though it also does business in Russia, according to a letter seen by Reuters.